"This is an exhilarating moment for Kraig Labs," said Kim Thompson, Founder and CEO of Kraig Labs. "BAM-1 Alpha represents the next step in the evolution of our spider silk technology. It's the result ...

EMA committee issues positive opinion to support the approval of GSK’s recombinant zoster vaccine, Shingrix in a prefilled syringe: London, UK Wednesday, October 22, 2025, 16:00 ...

The latest announcement is out from Novavax ( (NVAX) ).

CPV-104 is the only recombinant Factor H in clinical development and has received EU Orphan Drug Designation for C3GEleva successfully completed ...

Oral and inhaled biologics are gaining R&D investment due to patient acceptance and potential for home administration, with ...

Uniproma proudly introduces RJMPDRN REC, shortlisted for the 2025 Best Ingredient Award at in-cosmetics Latin America. As the ...

As research becomes ever more sophisticated and regulatory requirements tighten, ProPure ™ is a game-changer for life science ...

The global epigenetic antibodies market size is calculated at USD 2.70 billion in 2025 and is expected to reach around USD 12.01 billion by 2034, growing at a CAGR of 18.04% for the forecasted period.

Normally, Tau proteins stabilize microtubules and support neuronal function, but in neurodegenerative diseases such as ...

Vaxart, Inc. (OTCQX: VXRT) (“Vaxart”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that it ...

Cha Vaccine Research Institute, an affiliate of Cha Biotech, has unveiled its mid- to long-term growth strategy, focusing on ...

Over the past two years, Kraig Labs has used selective breeding to create more advanced parental strains with the goal of increasing hybrid vigor to further increase shell weight. One of these new ...